Stockreport

Aerie Pharmaceuticals Announces Positive Topline Results of Netarsudil Ophthalmic Solution in Pilot Phase 2 Study Supporting Clinical Development in Japan

Aerie Pharmaceuticals, Inc.  (AERI) 
Last aerie pharmaceuticals, inc. earnings: 2/20 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aeriepharma.com/investor-relations
PDF Announces Opening of Tokyo Branch Office and Two Key Hires in Japan DURHAM, N.C.--(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an o [Read more]